does semaglutide help with binge eating GLP-1 meds may reduce in obesity | Professor Erwin Loh posted on the topic GLP-1 receptor agonists: A novel

Clinical data shows 5060% of lost weight returns within one year

The etiology of ORG indicates that adipocytes release numerous lipids and inflammatory mediators in obesity, resulting in metabolic dysregulation, inflammation, and insulin resistance (IR), which contribute to glomerular hyperfiltration, damage, and atrophy of kidney units [7]

Cardiovascular Health: By helping patients manage weight and blood sugar, it indirectly supports cardiovascular health, reducing the risk of heart disease, stroke, and hypertension, all of which are closely linked to metabolic disorders

Saudi Medical Journal

The modest time savings (arriving at the maintenance dose two to four weeks earlier) does not offset the substantially worse side effect experience during those initial weeks

Some individuals even lost up to 20% of their initial weight